Dermatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Dermatitis, including details on contact-, seborrheic-, atopic-, allergic-dermatitis, treatment.

Volume 2 (2005), Issue 3 (March)

1. Ultraviolet A (320-400 nm) modulation of ultraviolet B (290-320 nm)-induced immune suppression is mediated by carbon monoxide.
   J Invest Dermatol, 124(3): 644-50. [Abstract] [Full-text]
2. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells.
   J Invest Dermatol, 124(3): 579-86. [Abstract] [Full-text]
3. Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8+ T cell functions.
   J Invest Dermatol, 124(3): 562-9. [Abstract] [Full-text]
4. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema.
   J Invest Dermatol, 124(3): 514-23. [Abstract] [Full-text]
5. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
   Intern Med J, 35(3): 188-90. [Abstract] [Full-text]
6. Bactericidal activity of flucloxacillin against Staphylococcus aureus in primary keratinocyte cultures of lesional and unaffected skin of patients suffering from atopic dermatitis.
   Exp Dermatol, 14(3): 215-24. [Abstract] [Full-text]
7. Inhibition of scratching behaviour caused by contact dermatitis in histidine decarboxylase gene knockout mice.
   Exp Dermatol, 14(3): 169-75. [Abstract] [Full-text]
8. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression.
   Eur J Immunol, 35(3): 690-8. [Abstract] [Full-text]
9. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
   BMJ, 330(7490): 516. [Abstract] [Full-text]
10. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1.
    J Neuroimmunol, 161(1): 87-92. [Abstract] [Full-text]
11. Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals.
    Regul Toxicol Pharmacol, 41(3): 159-66. [Abstract] [Full-text]
12. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Arch Gynecol Obstet, 271(2): 163-5. [Abstract] [Full-text]
13. Hypereosinophilic dermatitis-like erythema annulare centrifugum in a patient with chronic lymphocytic leukaemia.
    J Eur Acad Dermatol Venereol, 19(2): 228-31. [Abstract] [Full-text]
14. Dermatitis artefacta: unusual appearance in an older woman.
    J Eur Acad Dermatol Venereol, 19(2): 223-5. [Abstract] [Full-text]
15. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial.
    J Eur Acad Dermatol Venereol, 19(2): 172-5. [Abstract] [Full-text]
16. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.
    Photodermatol Photoimmunol Photomed, 21(2): 100-2. [Abstract] [Full-text]
17. UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center.
    Photodermatol Photoimmunol Photomed, 21(2): 93-6. [Abstract] [Full-text]
18. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
    Photodermatol Photoimmunol Photomed, 21(2): 62-7. [Abstract] [Full-text]
19. Ultraviolet-free phototherapy.
    Photodermatol Photoimmunol Photomed, 21(2): 59-61. [Abstract] [Full-text]
20. Recent highlights in the pathophysiology of atopic eczema.
    Int Arch Allergy Immunol, 136(2): 191-7. [Abstract] [Full-text]
21. Effects of TNCB sensitization in DS-Nh mice, serving as a model of atopic dermatitis, in comparison with NC/Nga mice.
    Int Arch Allergy Immunol, 136(2): 173-80. [Abstract] [Full-text]
22. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Int J Lepr Other Mycobact Dis, 72(4): 483-5. [Abstract] [Full-text]
23. Methotrexate in resistant ENL.
    Int J Lepr Other Mycobact Dis, 72(4): 480-2. [Abstract] [Full-text]
24. Skin disease in paper mill workers.
    Occup Med (Lond), 55(2): 109-12. [Abstract] [Full-text]
25. Infliximab in the treatment of moderate to severe atopic dermatitis.
    J Am Acad Dermatol, 52(3): 522-6. [Abstract] [Full-text]
26. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis.
    Clin Exp Immunol, 140(1): 101-8. [Abstract] [Full-text]
27. Additive impairment of the barrier function and irritation by biogenic amines and sodium lauryl sulphate: a controlled in vivo tandem irritation study.
    Skin Pharmacol Physiol, 18(2): 88-97. [Abstract] [Full-text]
28. Probable vancomycin-associated toxic epidermal necrolysis.
    Pharmacotherapy, 25(2): 308-12. [Abstract] [Full-text]
29. Drug-induced exanthems.
    Toxicology, 209(2): 131-4. [Abstract] [Full-text]
30. Breaking tolerance to nickel.
    Toxicology, 209(2): 119-21. [Abstract] [Full-text]
31. A comparison of adherence by four strains of Staphylococcus intermedius and Staphylococcus hominis to canine corneocytes collected from normal dogs and dogs suffering from atopic dermatitis.
    Res Vet Sci, 78(3): 193-8. [Abstract] [Full-text]
32. Norfloxacin-induced toxic epidermal necrolysis.
    Ann Pharmacother, 39(4): 768-70. [Abstract] [Full-text]
33. Guggenheimella bovis gen. nov., sp. nov., isolated from lesions of bovine dermatitis digitalis.
    Int J Syst Evol Microbiol, 55: 667-71. [Abstract] [Full-text]
34. Valdecoxib-associated acute generalized exanthematous pustulosis.
    Burns, 31(3): 383-7. [Abstract] [Full-text]
35. A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice.
    Int Arch Allergy Immunol, 136(3): 258-65. [Abstract] [Full-text]
36. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).
    Int Arch Allergy Immunol, 136(3): 205-16. [Abstract] [Full-text]
37. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
    Arch Dermatol Res, 296(10): 503-6. [Abstract] [Full-text]
38. Silicon image sensor technology for in vivo detection of surfactant-induced corneocyte swelling and drying.
    Dermatology, 210(3): 184-8. [Abstract] [Full-text]
39. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
    Clin Exp Allergy, 35(3): 382-7. [Abstract] [Full-text]
40. Deficiency in immunoglobulin G2 antibodies against staphylococcal enterotoxin C1 defines a subgroup of patients with atopic dermatitis.
    Clin Exp Allergy, 35(3): 274-81. [Abstract] [Full-text]
41. The chemokine receptor D6 limits the inflammatory response in vivo.
    Nat Immunol, 6(4): 403-11. [Abstract] [Full-text]
42. Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet.
    J Anim Physiol Anim Nutr (Berl), 89(3): 203-7. [Abstract] [Full-text]
43. Is rhinitis alone or associated with atopic eczema a risk factor for severe asthma in children?
    Pediatr Allergy Immunol, 16(2): 121-5. [Abstract] [Full-text]
44. Antigen specific cytokine response in pediatric patients with atopic dermatitis.
    Pediatr Allergy Immunol, 16(2): 113-20. [Abstract] [Full-text]
45. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
    Pediatr Allergy Immunol, 16(2): 97-103. [Abstract] [Full-text]
46. Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods.
    J Photochem Photobiol B, 79(1): 25-34. [Abstract] [Full-text]
47. Analysis of T cell receptor (TCR) BV-gene clonotypes in NC/Nga mice developing dermatitis resembling human atopic dermatitis.
    J Dermatol Sci, 38(1): 17-24. [Abstract] [Full-text]
48. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    J Dermatol Sci, 38(1): 9-15. [Abstract] [Full-text]

© 2004-2011 Dermatitis Research Today. All Rights Reserved.